PSP Research LLC
LAS VEGAS, NV · Quarter end: Sep 30, 2026 · Filed with SEC: Oct 21, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$145.8M2026 Q3Cash-like 48.3% · 2026 Q2: 37.5%Weight of Treasury-bill ETFs of a year or less (SGOV, BIL, SHV, USFR, TFLO…) in the book. A 13F shows no cash or money-market funds; this is the closest the filing comes. It is not the fund's actual cash level.
Positions44
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.95.0%
Top Holdings
SGOV
Ishares Tr
48.3%
XBI
SPDR Series
41.8%
SERA
Sera Prognostics
3.4%
HALO
Halozyme Therapeutics
0.2%
MDGL
Madrigal Pharmaceuticals
0.2%
EXEL
Exelixis
0.2%
RPRX
Royalty Pharma
0.2%
ARGX
Argenx
0.2%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.